Compare · head to head
GeneDx vs Intapp
Intapp ranks higher overall — 360 rank 24 vs 6.
Intapp leads on Value (48 vs 35), Quality (44 vs 28) and Growth (57 vs 24). GeneDx leads on Safety (42 vs 26) and Sentiment (59 vs 47).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Software & Internet |
| Industry | Health Care Providers & Services | Software |
| Size | Medium | Medium |
| ISIN | US81663L2007 | US45827U1097 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 6 | 24 |
| Value | 35 | 48 |
| Quality | 28 | 44 |
| Growth | 24 | 57 |
| Safety | 42 | 26 |
| Sentiment | 59 | 47 |
| Quality details | ||
| Profitability | 26 | 34 |
| Cash Truth | 30 | 54 |
GeneDx vs Upland SoftwareGeneDx vs SalesforceGeneDx vs SymboticGeneDx vs Viant TechnologyAdd a third stock →
Full analyses: GeneDx · Intapp
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100